US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,629.23

-13.5542-0.83%

Number of Gainers:2

Number of Losers:4

Number of Flat:1

PE:- -

High:1,643.38

Open:1,643.38

Low:1,613.30

Close:1,642.78

Volume:64.34M

Turnover:6.35B

Market Cap:1.70T

Float Cap:1.63T

Loading ...

NYSE Most Active Issues

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately

THOMSON REUTERS

Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance

THOMSON REUTERS

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk says China’s NMPA accepted application for marketing of Wegovy

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive from Peak

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

Novo Nordisk (0QIU) was downgraded to a Sell Rating at Deutsche Bank

Novo Nordisk Faces Growth Concerns Ahead of Important Investor Day

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK4599/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1629.2258,"timestamp":1788206399999,"preClose":1642.78,"halted":0,"volume":64344375,"delay":0,"changeRate":-0.008251,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.554199,"latestTime":"08-31 16:00:00 EDT","open":1643.3755,"high":1643.3755,"low":1613.2955,"amount":6350135301.509104,"amplitude":0.01831,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.887991,"peRate":29.004923,"turnoverRate":0.006049,"increases":2,"decrements":4,"flats":1,"marketCap":1695050126272,"floatMarketCap":1628782416800},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1643.3755,"amplitude":0.01831,"preClose":1642.78,"low":1613.2955,"pbRate":"9.887991","latestPrice":1629.2258,"volume":64344375,"delay":0,"open":1643.3755,"prevYearClose":1494.5856,"prevWeekClose":1642.78,"prevMonthClose":1583.5508,"prevQuarterClose":1614.7615,"fiveDayClose":1723.5714,"twentyDayClose":1555.1105,"sixtyDayClose":1531.676,"secType":"PLATE","market":"US","turnoverRate":0.006049,"peRate":29.004923,"marketCap":1695050126272,"floatMarketCap":1628782416800,"timestamp":1788206399999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":2,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662036856","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036856","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036856?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:40","pubTimestamp":1787866800,"startTime":"0","endTime":"0","summary":"BitMine Immersion Techs     BMNR    55,890,185     25.63     0.72      2.89. Nu Holdings Cl A              NU    47,688,503     14.88    -0.29     -1.91. Bank of America              BAC    44,490,310     61.17    -1.06     -1.70. Nike Cl B                    NKE    36,364,288     38.44    -0.15     -0.39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4592","LU2265009873.SGD","LU1074936037.SGD","VFH","FTXO","LU0170899867.USD","LU0070302665.USD","IYF","BK4585","KBWB","LU1069347547.HKD","IYG","BK4504","BK4207","LU1496350171.SGD","BK4599","LU0787776722.HKD","BK4561","IE00BLSP4452.SGD","FNCL","IE00B3T34201.USD","LU0130102774.USD","IE00B19Z3581.USD","LU2129689605.HKD","IE0034235188.USD","BK4543","LU0320765646.SGD","XLF","PATH","IE00B19Z3B42.SGD","LU0683600562.USD","LU0320765489.SGD","TFNS","PFE","SG9999003800.SGD","PATX","LU0417517546.SGD","LU1989771016.USD","LU1057294990.SGD","BK4533","LU0053666078.USD","LU0477156953.USD","LU0234572021.USD","LU0321505868.SGD","LU0456855351.SGD","LU0234570918.USD","BAC","OZEM","UYG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035516","title":"FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035516","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035516?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:04","pubTimestamp":1787864640,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.The agency gave a green light to supplemental biologics license applications for the 2026-2027 formulas to the Comirnaty vaccine, made by Pfizer and BioNTech, and Moderna's mNexspike and Spikevax shots. The new formulas are designed to target the XFG variant of Covid-19.Pfizer and BioNTech said the new formulation of its vaccine would begin shipping immediately for use beginning in the fall. Moderna said its updated vaccines will be available in the coming days.All three vaccines were approved for adults 65 years of age and older. The FDA also approved the shots for individuals younger than 65 whose underlying conditions put them at high risk for severe outcomes from Covid-19. Those approvals extend as young as 12 years old for mNexspike, five years for Comirnaty, and six months for Spikevax.\"Our updated COVID-19 vaccines help protect those at high risk of severe diseas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","IDNA","LU0306807586.USD","LU1023059063.AUD","IE00BBT3K403.USD","BK4533","IE00B3T34201.USD","SG9999013999.USD","LU0456855351.SGD","LU2596442595.SGD","SG9999002232.USD","BK4007","SG9999011175.SGD","BK4551","PFE","IE00BLSP4239.USD","LU0225771236.USD","LU0234572021.USD","LU1894683348.USD","LU1066053197.SGD","WDNA","SG9999001176.SGD","BK4534","BK4568","LU0225284248.USD","IE0002270589.USD","BK4599","IE00BLSP4452.SGD","LGHT","MRNX","LU0321505868.SGD","LU0321505439.SGD","SG9999002224.SGD","OZEM","SG9999001176.USD","LU1894683264.USD","BK4588","BNTX","MRNY","BK4585","LU0985481810.HKD","SGXZ57979304.SGD","BK4535","BK4592","LU1057294990.SGD","LU0289739699.SGD","BK4548","LU0170899867.USD","GNOM","LU0058720904.USD","BK4532","LU0306806265.USD","LU0122379950.USD","LU1883839398.USD","LU1066051498.USD","MRNA","SG9999003800.SGD","LU0868494617.USD","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4581","BK4550","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033176","title":"Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033176","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033176?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:35","pubTimestamp":1787862915,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) and BioNTech (BNTX) announced that the FDA has approved the supplemental Biologics License Application for the companies’ 2026-2027 CO...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-and-biontech-receive-fda-approval-for-xfg-adapted-covid-19-vaccine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-and-biontech-receive-fda-approval-for-xfg-adapted-covid-19-vaccine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4533","BK4007","IE00BLSP4452.SGD","LU0306807586.USD","IE00BLSP4239.USD","BK4548","BK4534","IE00B19Z3B42.SGD","LU2596442595.SGD","SG9999001176.SGD","LU1894683348.USD","BK4588","LU0225284248.USD","LU0122379950.USD","LU0985481810.HKD","LU0170899867.USD","LU0321505439.SGD","IE00BBT3K403.USD","BK4550","BNTX","IE000M9KFDE8.USD","LU0306806265.USD","LU1057294990.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU1883839398.USD","BK4599","LU0456855351.SGD","BK4535","LU1023059063.AUD","SG9999003800.SGD","LU0868494617.USD","OZEM","BK4139","SG9999002224.SGD","BK4568","LU1894683264.USD","PFE","LU0225771236.USD","SG9999011175.SGD","BK4581","BK4551","LU0289739699.SGD","LU0321505868.SGD","SG9999002232.USD","BK4585","IE00B3T34201.USD","BK4592","LU1066051498.USD","LU0234572021.USD","LU1066053197.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203332","title":"Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203332","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203332?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:31","pubTimestamp":1787862691,"startTime":"0","endTime":"0","summary":"Pfizer, BioNTech win FDA approval for XFG-adapted COVID-19 vaccine in high-risk US adultsFDA cleared Pfizer’s supplemental filing for an XFG-adapted COMIRNATY COVID-19 shot for the 2026-2027 season.Au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8F62z4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4534","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1066051498.USD","BK4139","IE000M9KFDE8.USD","LU0234572021.USD","SG9999001176.USD","LU0225284248.USD","BK4585","LU0306807586.USD","LU1894683348.USD","OZEM","SG9999003800.SGD","LU0321505439.SGD","SG9999011175.SGD","IE00B3T34201.USD","PFE","SGXZ57979304.SGD","LU0985481810.HKD","LU1057294990.SGD","IE00B19Z3B42.SGD","BK4592","IE00B19Z3581.USD","BK4551","BK4007","BK4568","LU1883839398.USD","SG9999002224.SGD","LU0456855351.SGD","BK4599","IE0002270589.USD","SG9999002232.USD","LU2596442595.SGD","BK4581","BK4533","BK4548","LU0868494617.USD","BK4550","LU0122379950.USD","SG9999013999.USD","BK4588","LU1066053197.SGD","BNTX","IE00BBT3K403.USD","LU1894683264.USD","LU0289739699.SGD","LU0306806265.USD","LU0058720904.USD","LU1023059063.AUD","LU0225771236.USD","SG9999001176.SGD","LU0170899867.USD","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403380","title":"Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403380?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:30","pubTimestamp":1787862600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7VLGST:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0456855351.SGD","LU0225771236.USD","BK4592","LU1023059063.AUD","LU1883839398.USD","LU0985481810.HKD","LU1057294990.SGD","IE00B19Z3581.USD","SG9999002224.SGD","SG9999001176.USD","BK4581","BK4007","LU1894683264.USD","LU0321505439.SGD","BK4599","SG9999003800.SGD","IE00BLSP4452.SGD","LU1066051498.USD","IE00B3T34201.USD","BK4534","LU2596442595.SGD","SG9999001176.SGD","LU0225284248.USD","LU0868494617.USD","BK4568","LU0122379950.USD","LU0058720904.USD","SG9999011175.SGD","SGXZ57979304.SGD","BK4585","LU1894683348.USD","LU0321505868.SGD","BK4588","BK4533","IE0002270589.USD","IE00BBT3K403.USD","PFE","LU0306806265.USD","OZEM","BK4550","LU0306807586.USD","LU0289739699.SGD","SG9999013999.USD","SG9999002232.USD","LU1066053197.SGD","LU0170899867.USD","LU0234572021.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662382033","title":"Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2662382033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662382033?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:30","pubTimestamp":1787862600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7VLGST:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU0058720904.USD","SG9999002232.USD","BK4585","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU2596442595.SGD","SG9999003800.SGD","LU0985481810.HKD","LU1894683264.USD","IE0002270589.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU1894683348.USD","BK4550","SG9999002224.SGD","LU0225771236.USD","BK4592","LU0321505868.SGD","LU0868494617.USD","LU1066051498.USD","BK4007","LU0122379950.USD","LU1023059063.AUD","LU1066053197.SGD","LU1883839398.USD","LU0289739699.SGD","LU0456855351.SGD","IE00B19Z3581.USD","IE00B3T34201.USD","PFE","SG9999001176.USD","SG9999013999.USD","OZEM","LU0170899867.USD","SG9999011175.SGD","LU0306806265.USD","LU1057294990.SGD","LU0225284248.USD","IE00BBT3K403.USD","LU0321505439.SGD","IE00BLSP4239.USD","BK4534","BK4599","LU0306807586.USD","BK4581","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084187","title":"Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084187","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084187?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848308,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has started a new Phase 1 trial called “A Phase 1, Open-La...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","PJP","SG9999001440.SGD","LU0320765992.SGD","LU2242646821.SGD","BK4585","BIB","IE0002141913.USD","TBXU","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","IE00BJJMRZ35.SGD","BK4599","LU1061106388.HKD","IBB","BBH","LU0868494617.USD","LU1023059063.AUD","LU1983299246.USD","LU2242652126.USD","LU0889565916.HKD","LU2112291526.USD","LU0109394709.USD","BK4139","BK4581","LU0058720904.USD","LU0122379950.USD","BK4588","BBC","BK4566","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","AMGN","BK4533","IBBQ","IE0009355771.USD","LU1057294990.SGD","LU0289739699.SGD","PBE","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084918","title":"Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084918","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084918?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:30","pubTimestamp":1787848217,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. is reporting new data from its Korean post-marketing study of Vy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-korean-vyndamax-study-update-what-it-means-for-attr-cm-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-korean-vyndamax-study-update-what-it-means-for-attr-cm-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BLSP4239.USD","BK4534","IE00BBT3K403.USD","IE00B3T34201.USD","LU0225284248.USD","LU0321505439.SGD","LU0456855351.SGD","SG9999001176.USD","LU0306806265.USD","LU1883839398.USD","SG9999013999.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU0234572021.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU1066051498.USD","SGXZ57979304.SGD","LU0122379950.USD","LU1057294990.SGD","SG9999001176.SGD","LU0289739699.SGD","BK4581","IE0002270589.USD","SG9999002224.SGD","SG9999002232.USD","PFE","BK4007","SG9999011175.SGD","BK4550","LU2596442595.SGD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0170899867.USD","LU1894683348.USD","BK4585","LU0225771236.USD","BK4568","LU0985481810.HKD","OZEM","LU0868494617.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4599","LU1894683264.USD","SG9999003800.SGD","BK4533","LU0306807586.USD","BK4588","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662812320","title":"Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55","url":"https://stock-news.laohu8.com/highlight/detail?id=2662812320","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662812320?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:29","pubTimestamp":1787844592,"startTime":"0","endTime":"0","summary":"Eli Lilly (NYSE: LLY) reported new independent real-world evidence that its obesity treatment Zepbound (tirzepatide) is linked to lower overall healthcare costs for adults over 55 with obesity.\nThe analysis indicates these cost savings appear as early as 12 months after starting Zepbound treatment in this older patient group.\nThe findings focus on total healthcare spending rather than drug costs alone and suggest a potential economic advantage for Zepbound in routine clinical use.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-says-zepbound-cuts-healthcare-costs-for-adults","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-says-zepbound-cuts-healthcare-costs-for-adults","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015952.SGD","SG9999014906.USD","LU1023059063.AUD","SG9999014880.SGD","SG9999001176.SGD","SG9999015945.SGD","LU0122379950.USD","LU2237443382.USD","LU1629891620.HKD","IE00B4R5TH58.HKD","LU2750360997.AUD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","LU0820561818.USD","LU0353189680.USD","LU0882574055.USD","LLII","LU2602419157.SGD","SGXZ99366536.SGD","LU0882574139.USD","LU1291159041.SGD","LU2265009873.SGD","LU2461242641.AUD","LU1868836591.USD","BK4585","LU2111349929.HKD","LU2360106947.USD","IE00B7KXQ091.USD","LU2552382215.SGD","IE0009355771.USD","LU0289739699.SGD","LU2106854487.HKD","LU2168564149.EUR","LU2361044865.SGD","IE00BWXC8680.SGD","LU2361045086.USD","SGXZ51526630.SGD","LU0823416689.USD","GB00BDT5M118.USD","LU0203202063.USD","LU0471298694.HKD","LU2089984988.USD","LU0787776722.HKD","LU0417517546.SGD","LU1061106388.HKD","LU1035775433.USD","TMED","SG9999018857.SGD","FHLC","IE00BFTCPJ56.SGD","LU2237443549.SGD","ELIL","LU2237443465.HKD","LU2236285917.USD","LU0320765992.SGD","LU2324357040.USD","LU0345770993.USD","LLY","LU0640476718.USD","LU0456855351.SGD","IE00BKDWB100.SGD","LLYX","RXL","JDOC","BK4516","LU0058720904.USD","LU1323610961.USD","LU2471134796.USD","THNR","IE00B1XK9C88.USD","LU2462591350.SGD","LU1868837136.USD","LU0320765059.SGD","LU1551013425.SGD","LU0672654240.SGD","IE00B775H168.HKD","LU2168564495.EUR","LU1917777945.USD","PJP","LU0689472784.USD","LU1127390331.HKD","LU1712237335.SGD","LU2108987350.USD","LU0466842654.USD","LU0061475181.USD","LU2750360641.GBP","LU0158827781.USD","LU0820561909.HKD","LU0820562030.AUD","LU0889565916.HKD","LU1267930730.SGD","LU1280957306.USD","LU2271345857.HKD","SG9999014914.USD","BK4533","LU0266013472.USD","IE00BJJMRZ35.SGD","CURE","LU0097036916.USD","LU1623119135.USD","ILDR","BK4007","LU2756315318.SGD","LU2023251221.USD","LU0964807845.USD","LU1064131342.USD","LU0114720955.EUR","IE00BJJMRX11.SGD","LU1145028129.USD","LU1868836914.USD","SGXZ57979304.SGD","LLYZ","LU2237438978.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU1989771016.USD","LU0109391861.USD","LU2491049909.HKD","ELIS","LU0174119429.USD","LU0203201768.USD","FTXH","LU1983299246.USD","LU0238689110.USD","LU0345770308.USD","OZEM","LU1988902786.USD","LU2456880835.USD","LU1974910355.USD","LU2896262040.SGD","BK4534","LU0943347566.SGD","LU1804176565.USD","LU0385154629.USD","LU2237443895.HKD","LU1868837300.USD","LU2491050071.SGD","SG9999015986.USD","LU2357305700.SGD","LU2361044949.HKD","LU0096364046.USD","LU1720051017.SGD","AGNG","LU1979441026.SGD","LU2168564065.EUR","LU2213496289.HKD","LU2028103732.USD","LU0471298777.SGD","LU0198837287.USD","LU2746668974.SGD","IE00BK4W5M84.HKD","LU0006306889.USD","WDNA","LU0133085943.USD","LU0353189763.USD","LU2746668461.USD","LU1057294990.SGD","LU1548497426.USD","LU0234572021.USD","IE0005OL40V9.USD","LU1093756168.USD","LU0432979614.USD","LU2471134879.HKD","IE00BK4W5L77.USD","LU2063271972.USD","LU1720051108.HKD","LU2168563687.JPY","LU2087625088.SGD","SG9999013999.USD","BK4581","IE00B1BXHZ80.USD","LU1366192091.USD","LU0256863811.USD","LU2112291526.USD","LU2237443622.USD","LU2023250504.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0158827948.USD","LU0683600562.USD","LU0354030438.USD","LU1691799644.USD","LU1868836757.USD","LU0316494557.USD","LU2089283258.USD","SG9999001176.USD","HRTS","IE00BN29S564.USD","LU2491050154.USD","LU2417539215.USD","SG9999017495.SGD","MEDX","TRUH","IE0002141913.USD","IE00BJJMRY28.SGD","LU0708995401.HKD","SG9999014898.SGD","GDOC","LU1551013342.USD","IE00BKPKM429.USD","BK4599","LU2211815571.USD","LU2264538146.SGD","LU2468319806.SGD","LU2552382058.USD","LU2471134952.CNY","MEDI","LU2552382132.HKD","LU0786609619.USD","LU2462157665.USD","BK4588","LU1069344957.HKD","LU0823434583.USD","SG9999015978.USD","SG9999018865.SGD","LU0354030511.USD","LU2023250330.USD","IE00B4JS1V06.HKD","SGXZ81514606.USD","IHE","LU0256863902.USD","SGXZ31699556.SGD","PPH","IE0004445239.USD","LU0094547139.USD","CANC","LU0823434740.USD","IE0004445015.USD","LU0106261372.USD","LU1093756325.SGD","LU1232071149.USD","LU1814569148.SGD","LU2089284900.SGD","LU2237443978.SGD","LU2471134523.USD","LU2168564222.USD","LU0323591593.USD","LU0210536198.USD","LU0079474960.USD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","IE00B4R5TH58.HKD","BK4137","HCSG","LU2242646821.SGD","LU1571399168.USD","BK4585","SG9999001440.SGD","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","LABU","LU0128526141.USD","BK4599","BBH","LU0868494617.USD","LU0058720904.USD","LU2468319806.SGD","IE0002141913.USD","XLV","BK4588","LU0320765992.SGD","LU0122379950.USD","AMGN","LU1023059063.AUD","LU2112291526.USD","PBE","LU0889565916.HKD","TBXU","LU1983299246.USD","LU0289739699.SGD","VRCA","PJP","LU0109394709.USD","LU1057294990.SGD","BK4533","IE00B2B36J28.USD","LU2089984988.USD","BK4581","IBB","IBBQ","XBI","LU2242652126.USD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","LU0029874061.USD","BK4007","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084083","title":"HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084083","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:01","pubTimestamp":1787839287,"startTime":"0","endTime":"0","summary":"HBM Holdings FY26 H1 profit falls 11.16% to US$ 64.85 million; revenue rises 20.9% to US$ 122.49 millionHBM Holdings posted revenue of US$122.49 million for the six months ended June 30, 2026, up 20.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL77D5HK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","BIB","BK4533","LU0109394709.USD","BK1161","BK1574","LU1983299246.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2089984988.USD","LU2242646821.SGD","LU0058720904.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4139","IE00BFTCPJ56.SGD","AMGN","BK4566","IE0002141913.USD","LU1571399168.USD","LU2468319806.SGD","BK4599","TBXU","PJP","LU1061106388.HKD","LU0889565916.HKD","LU2242652126.USD","BK4581","PBE","LU0289739699.SGD","IBBQ","IBB","LU0320765992.SGD","02142","IE00B2B36J28.USD","BK1583","LU1057294990.SGD","LU2112291526.USD","LU0868494617.USD","BK4585","BK4534","BBH","SG9999001440.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662083487","title":"Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2662083487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662083487?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:51","pubTimestamp":1787838660,"startTime":"0","endTime":"0","summary":"Novo Nordisk shares slipped Thursday after Deutsche Bank downgraded the stock's rating on concerns over the company's future growth potential.Shares were 3.3% lower in afternoon Copenhagen trade after","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","PPH","IE00BKVL7J92.USD","BK4599","LU1093756325.SGD","NVOH","NVOX","NVO","OZEM","NVOC","LU0154236417.USD","THNR","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662007177","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662007177","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662007177?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:01","pubTimestamp":1787835662,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  0.7% lower and the iShares Biotechnology ETF  down 0.5%.Novo Nordisk  said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","BK4532","IE00BKVL7J92.USD","BK4007","OZEM","PPH","NVO","BK4599","NVOC","LU1093756168.USD","BK4581","NVOH","THNR","LU1093756325.SGD","LU0154236417.USD","XBI","IBB","IE00BZ1G4Q59.USD","XLV","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068647","title":"Novo Nordisk says China’s NMPA accepted application for marketing of Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068647?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826613,"startTime":"0","endTime":"0","summary":"The official website of the Center for Drug Evaluation of China’s National Medical Products Administration, NMPA, shows that Novo Nordisk’s (NVO) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-chinas-nmpa-accepted-application-for-marketing-of-wegovy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-chinas-nmpa-accepted-application-for-marketing-of-wegovy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","NVOC","IE00BKVL7J92.USD","NVO","PPH","IE00BZ1G4Q59.USD","BK4007","OZEM","LU0154236417.USD","NVOX","BK4532","THNR","BK4599","NVOH","BK4585","BK4588","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2112291526.USD","LU0058720904.USD","BK4568","AZNH","IE0002141913.USD","BK4588","AMGN","IE00BJT1NW94.SGD","LU1267930573.SGD","BK4007","LU0128525929.USD","LU2468319806.SGD","PBE","LU0889565916.HKD","PJP","LU0122379950.USD","TBXU","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","LU1061106388.HKD","LU1571399168.USD","LU2417539215.USD","BK4533","BK4581","BK4599","AZN","IBBQ","IE00B2B36J28.USD","LU2237443895.HKD","LU1829250122.USD","BK4585","LU1057294990.SGD","LU2236285917.USD","LU2237443465.HKD","LU2237443978.SGD","IE0009355771.USD","LU1983299246.USD","BK4566","BIB","LU1023059063.AUD","IE00B3T34201.USD","BBH","LU0029864427.USD","LU2456880835.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU2242646821.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774895","title":"Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive from Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774895","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774895?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:37","pubTimestamp":1787819820,"startTime":"0","endTime":"0","summary":"Novo Nordisk was downgraded to sell by Deutsche Bank.While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, u","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVOH","THNR","OZEM","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4599","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4585","BK4007","NVO","NVOC","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","IE00BJT1NW94.SGD","TBXU","AZN","LU0889565916.HKD","BBH","LU1983299246.USD","LU2242652126.USD","LU2237443382.USD","IBBQ","LU1061106388.HKD","BK4007","BK4533","LU2242646821.SGD","LU0128525929.USD","LU1829250122.USD","AMGN","LU2237443622.USD","AZNH","IE00BJJMRZ35.SGD","LU2237443978.SGD","IBB","LU0868494617.USD","LU2237443465.HKD","LU2456880835.USD","BK4585","LU1057294990.SGD","LU2112291526.USD","LU0432979614.USD","LU1267930573.SGD","PBE","LU2089984988.USD","LU0289739699.SGD","IE00B2B36J28.USD","BIB","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","PJP","LU0058720904.USD","LU0708994859.HKD","LU0109394709.USD","BK4534","LU0310800379.SGD","LU2462157665.USD","LU2237443895.HKD","BK4599","LU2237443549.SGD","BK4581","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719779","title":"Novo Nordisk (0QIU) was downgraded to a Sell Rating at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719779?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:35","pubTimestamp":1787816126,"startTime":"0","endTime":"0","summary":"Novo Nordisk received a Sell rating and a DKK265.00 price target from Deutsche Bank analyst Emmanuel Papadakis today. Papadakis covers the Healthca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-was-downgraded-to-a-sell-rating-at-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-was-downgraded-to-a-sell-rating-at-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","NVOC","BK4118","IE00BKVL7J92.USD","LU1093756325.SGD","BK4566","PPH","NVOH","BK4588","LU1093756168.USD","BK4007","BK4552","DB","IE00BZ1G4Q59.USD","BK4532","NVOX","NVO","BK4585","LU0154236417.USD","BK4599","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662400776","title":"Novo Nordisk Faces Growth Concerns Ahead of Important Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662400776","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662400776?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:22","pubTimestamp":1787815320,"startTime":"0","endTime":"0","summary":"0721 GMT - Novo Nordisk faces persistent concerns over the scope for a return to growth in 2027 and a large patent cliff problem further out, Deutsche Bank analyst Emmanuel Papadakis writes. The bank also notes that a bump in U.S. Medicare prescriptions looks limited, while Novo Nordisk's ziltivekimab is now effectively out of the picture, after the drug failed to reduce risk of heart attack or stroke in a late-stage clinical trial. The company has an important capital markets day next month, the bank adds. Deutsche Bank downgrades the stock to sell from hold and lowers its target price to 265 Danish kroner from 290 kroner. Shares fall 1.6% to 300.10 kroner.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","BK4532","LU1093756168.USD","BK4588","OZEM","PPH","NVOC","NVOX","BK4599","THNR","BK4007","IE00BKVL7J92.USD","NVOH","LU1093756325.SGD","NVO","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0575583348.USD","REGN","AZN.UK","LU0345777659.USD","LU2237443382.USD","LU1880407132.USD","LU1829250122.USD","LU0122379950.USD","LU0887340254.USD","AMGN","LU0997586515.USD","LU1267930490.SGD","BIB","LU2242652126.USD","BK4588","LU0077335932.USD","PJP","LU0266013472.USD","LU1481600234.SGD","LU0972486137.USD","BK4599","LU0792757196.USD","LU0738911758.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1119994496.HKD","LU0310799852.SGD","IBB","LU1003077747.HKD","LU0997586432.USD","BBH","PBE","IBBQ","LU0823434583.USD","TBXU","LU0661504455.SGD","LU0052756011.USD","LU2237443622.USD","03165","LU3187612489.SGD","LU2293690082.USD","LU0640478417.SGD","LU1051770623.HKD","LU1153584641.USD","LU1974910355.USD","LU0432979614.USD","LU1170363599.USD","LU1571399168.USD","SGXZ57979304.SGD","LU0047473722.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":197,"code":"91000000","status":"200"}]}}